cover image - Evolve Resources for Clinical Manifestations & Assessment of Respiratory Disease, 9th Edition
ISBN: 9780323871549
Copyright: 2024
Publication Date: 04-11-2023
Page Count: 672
Imprint: Mosby
List Price: $34.99

Evolve Resources for Clinical Manifestations & Assessment of Respiratory Disease, 9th Edition

by Terry Des Jardins, MEd, RRT and George G. Burton, MD, FACP, FCCP, FAARC

Resources

cover image - Evolve Resources for Clinical Manifestations & Assessment of Respiratory Disease, 9th Edition
ISBN: 9780323871549
Copyright: 2024
Publication Date: 04-11-2023
Page Count: 672
Imprint: Mosby
List Price: $34.99
For Qualified Instructors.
Important note
This is a Faculty Product!
Any student who attempts to register for access will be reported to the school's faculty and administration.

Educator Resources on Evolve

  • Test bank
  • PowerPoint® slides
  • Image collection
  • NBRC® correlation guide
  • Conversion guide

Student Resources on Evolve

  • NBRC® correlation guide
  • Self-assessment questions and answers
  • Case studies
  • Appendices
  • Glossary
  • References
  • Bibliographies
  • PART 1: Assessment of Cardiopulmonary Disease

    SECTION I: Bedside Diagnosis

    1. The Patient Interview
    2. The Physical Examination
    3. The Pathophysiologic Basis for Common Clinical Manifestations
    4. SECTION II: CLINICAL DATA OBTAINED FROM LABORATORY TESTS AND SPECIAL PROCEDURES—Objective Findings

    5. Pulmonary Function Testing
    6. Blood Gas Assessment
    7. Assessment of Oxygenation
    8. Assessment of the Cardiovascular System
    9. Radiologic Examination of the Chest
    10. Other Important Tests and Procedures
    11. SECTION III: THE THERAPIST-DRIVEN PROTOCOL PROGRAM—THE ESSENTIALS

    12. The Therapist-Driven Protocol Program
    13. Respiratory Insufficiency, Respiratory Failure and Ventilatory Management Protocols
    14. Recording Skills and Intra-Professional Communication
    15. PART II: Obstructive Lung Disease

    16. Chronic Obstructive Pulmonary Disease, Chronic Bronchitis and Emphysema
    17. Asthma
    18. Cystic Fibrosis
    19. Bronchiectasis
    20. PART III: Loss of Alveolar Volume

    21. Atelectasis
    22. PART IV: Infectious Pulmonary Disease

    23. Pneumonia, Lung Abscess Formation and Important Fungal Diseases
    24. Tuberculosis
    25. PART V: Pulmonary Vascular Disease

    26. Pulmonary Edema
    27. Pulmonary Vascular Disease: Pulmonary Embolism and Pulmonary Hypertension
    28. PART VI: Chest and Pleural Trauma

    29. Flail Chest
    30. Pneumothorax
    31. PART VII: Disorders of the Pleura and of the Chest Wall

    32. Pleural Effusion and Empyema
    33. Kyphoscoliosis
    34. PART VIII: Lung Cancer

    35. Cancer of the Lung: Prevention and Palliation
    36. PART IX: Environmental Lung Diseases

    37. Interstitial Lung Diseases
    38. PART X: Diffuse Alveolar Disease

    39. Acute Respiratory Distress Syndrome
    40. PART XI: Neuro-Respiratory Disorders

    41. Guillain-Barre Syndrome
    42. Myasthenia Gravis
    43. Respiratory Insufficiency in the Patient with Neuro-Respiratory Disease
    44. PART XII: Sleep-Related Breathing Disorders

    45. Sleep Apnea
    46. PART XIII: Newborn and Early Childhood Cardiopulmonary Disorders

    47. The Newborn Disorders
    48. Pediatric Assessment, Protocols, and PALS Management
    49. Meconium Aspiration Syndrome
    50. Transient Tachypnea of the Newborn
    51. Respiratory Distress Syndrome
    52. Pulmonary Air Leak Syndrome
    53. Respiratory Syncytial Virus Infection (Bronchiolitis)
    54. Chronic Lung Disease of Infancy
    55. Congenital Diaphragmatic Hernia
    56. Congenital Heart Disease
    57. Croup and Croup-like Syndromes: Laryngotracheobronchitis, Bacterial Tracheitis and Acute Epiglottitis
    58. PART XIV: Other Important Topics

    59. Near Drowning/Wet Drowning Smoke Inhalation, Thermal Injuries, and Carbon Monoxide Intoxication

    Appendix I

    Symbols and Abbreviations Commonly Used in Respiratory Physiology

    Appendix II

    Agents Used to Treat Bronchospasm and Airway Inflammation

    Appendix III

    Antibiotics

    Appendix IV

    Antifungal Agents

    Appendix V

    Mucolytic and Expectorant Agents

    Appendix VI

    Positive Inotropes and Vasopressors

    Appendix VII

    Diuretic Agents

    Appendix VIII

    The Ideal Alveolar Gas Equation

    Appendix IX

    Physiologic Dead Space Calculation

    Appendix X

    Units of Measure

    Appendix XI

    Poiseuille’s Law

    Appendix XII

    PCO2/HCO3_/pH Nomogram

    Appendix XIII

    Calculated Hemodynamic Measurements

    Appendix XIV

    DuBois Body Surface Area Chart

    Appendix XV

    Cardiopulmonary Profile

    Appendix XVI

    Answers to Self-Assessment Questions

    Glossary

    Index

    PART 1: Assessment of Cardiopulmonary Disease

    SECTION I: Bedside Diagnosis

    1. The Patient Interview
    2. The Physical Examination
    3. The Pathophysiologic Basis for Common Clinical Manifestations
    4. SECTION II: CLINICAL DATA OBTAINED FROM LABORATORY TESTS AND SPECIAL PROCEDURES—Objective Findings

    5. Pulmonary Function Testing
    6. Blood Gas Assessment
    7. Assessment of Oxygenation
    8. Assessment of the Cardiovascular System
    9. Radiologic Examination of the Chest
    10. Other Important Tests and Procedures
    11. SECTION III: THE THERAPIST-DRIVEN PROTOCOL PROGRAM—THE ESSENTIALS

    12. The Therapist-Driven Protocol Program
    13. Respiratory Insufficiency, Respiratory Failure and Ventilatory Management Protocols
    14. Recording Skills and Intra-Professional Communication
    15. PART II: Obstructive Lung Disease

    16. Chronic Obstructive Pulmonary Disease, Chronic Bronchitis and Emphysema
    17. Asthma
    18. Cystic Fibrosis
    19. Bronchiectasis
    20. PART III: Loss of Alveolar Volume

    21. Atelectasis
    22. PART IV: Infectious Pulmonary Disease

    23. Pneumonia, Lung Abscess Formation and Important Fungal Diseases
    24. Tuberculosis
    25. PART V: Pulmonary Vascular Disease

    26. Pulmonary Edema
    27. Pulmonary Vascular Disease: Pulmonary Embolism and Pulmonary Hypertension
    28. PART VI: Chest and Pleural Trauma

    29. Flail Chest
    30. Pneumothorax
    31. PART VII: Disorders of the Pleura and of the Chest Wall

    32. Pleural Effusion and Empyema
    33. Kyphoscoliosis
    34. PART VIII: Lung Cancer

    35. Cancer of the Lung: Prevention and Palliation
    36. PART IX: Environmental Lung Diseases

    37. Interstitial Lung Diseases
  • Terry Des Jardins, MEd, RRT, Director, Professor Emeritus, Department of Respiratory Care, Parkland College, Champaign, Illinois. and George G. Burton, MD, FACP, FCCP, FAARC, Associate Dean for Medical Affairs, Kettering College of Medical Arts, Kettering, Ohio; Clinical Professor of Medicine and Anesthesiology, Wright State University School of Medicine, Dayton, Ohio.
  • This product is available in the following formats:
    Blackboard Learn
    Brightspace by D2L
    Canvas by Instructure
    Evolve Global Course
    Evolve (Elsevier)
    Moodle
    Other LMS
    Sakai
For Qualified Instructors.
Important note
This is a Faculty Product!
Any student who attempts to register for access will be reported to the school's faculty and administration.